Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective

被引:19
|
作者
Burnier, Michel [1 ]
Wuerzner, Gregoire [1 ]
Bochud, Murielle [2 ]
机构
[1] Univ Lausanne Hosp, Dept Med, Serv Nephrol & Hypertens, Lausanne, Switzerland
[2] Univ Lausanne Hosp, Inst Univ Med Sociale & Prevent, Lausanne, Switzerland
来源
FRONTIERS IN PHYSIOLOGY | 2015年 / 6卷
关键词
blood pressure; sodium; potassium; health strategies; hypertension; cardiovascular risk; DIETARY-SODIUM INTAKE; LEFT-VENTRICULAR MASS; URINARY SODIUM; POTASSIUM EXCRETION; REDUCTION; HYPERTENSION; SENSITIVITY; DISEASE; METAANALYSIS; MORTALITY;
D O I
10.3389/fphys.2015.00227
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Among the various strategies to reduce the incidence of non-communicable diseases reduction of sodium intake in the general population has been recognized as one of the most cost-effective means because of its potential impact on the development of hypertension and cardiovascular diseases. Yet, this strategic health recommendation of the WHO and many other international organizations is far from being universally accepted. Indeed, there are still several unresolved scientific and epidemiological questions that maintain an ongoing debate. Thus what is the adequate low level of sodium intake to recommend to the general population and whether national strategies should be oriented to the overall population or only to higher risk fractions of the population such as salt-sensitive patients are still discussed. In this paper, we shall review the recent results of the literature regarding salt, blood pressure and cardiovascular risk and we present the recommendations recently proposed by a group of experts of Switzerland. The propositions of the participating medical societies are to encourage national health authorities to continue their discussion with the food industry in order to reduce the sodium intake of food products with a target of mean salt intake of 5-6 grams per day in the population. Moreover, all initiatives to increase the information on the effect of salt on health and on the salt content of food are supported.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] A Higher Salt Intake Leads to a Lower Rate of Adequate Blood Pressure Control
    Lee, Jeonghwan
    Lee, Hajeong
    Kim, Kiwon
    Park, Jung Hwan
    Kim, Suhnggwon
    Oh, Jieun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 : S103 - S108
  • [2] What is the true place of blood pressure in cardiovascular risk management?
    McInnes, Gordon T.
    JOURNAL OF HYPERTENSION, 2007, 25 (05) : 925 - 928
  • [3] Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival
    Franco, Veronica
    Oparil, Suzanne
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2006, 25 (03) : 247S - 255S
  • [4] Preventive Cardiovascular Measures in Children with Elevated Blood Pressure
    Mocnik, Mirjam
    Varda, Natasa Marcun
    LIFE-BASEL, 2024, 14 (08):
  • [5] Is daytime blood pressure adequate in cardiovascular risk assessment in patients with coronary atherosclerosis?
    Sobiczewski, Wojciech
    Wirtwein, Marcin
    Gruchala, Marcin
    BLOOD PRESSURE, 2014, 23 (02) : 96 - 101
  • [6] Impact of risk factors on cardiovascular risk: a perspective on risk estimation in a Swiss population
    Chrubasik-Hausmann, Sigrun
    Chrubasik, Cosima
    Piper, Joerg
    Moenting, Juergen Schulte
    Erne, Paul
    SWISS MEDICAL WEEKLY, 2015, 145
  • [7] Blood pressure and cardiovascular risk: What about cocoa and chocolate?
    Grassi, Davide
    Desideri, Giovambattista
    Ferri, Claudio
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 501 (01) : 112 - 115
  • [8] Blood pressure and control of cardiovascular risk
    Whitworth, Judith A.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2005, 1 (03) : 257 - 260
  • [9] Glucose, Blood Pressure, and Cardiovascular Risk
    Lleva, Ranee R.
    Inzucchi, Silvio E.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (02): : 145 - 147
  • [10] SALT INTAKE, BLOOD-PRESSURE, AND CARDIOVASCULAR STRUCTURE
    BEIL, AH
    SCHMIEDER, RE
    MESSERLI, FH
    CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (03) : 425 - 432